Signing from left: Dr. Kenji M. Asano Jr., MOHS senior vice president and group chief financial officer; Remedios A. Rivera, Remed chairman and president; and Michael B. Hortaleza, MOHS chairman and chief executive officer Remed Pharmaceuticals Inc., a research and development driven company founded in 2002 by pharmaceutical industry pillar Remedios A. Rivera.
From left: Dr. Kenji M. Asano, Jr., MOHS senior vice president and group chief financial officer; Remedios A. Rivera, Remed chairman and president; and Michael B. Hortaleza, MOHS chairman and chief executive officer and Jocelyn M. Aberin, Remed vice president for operations MOHS got a jump start in business by being among the first to bring in affordable test kits and equipment at the start of the COVID-19 pandemic. With the decline of the COVID business, MOHS quickly pivoted to affordable point of care and home test kits for the early detection of diseases such as urinary tract infection, dengue and malaria.
“Remed’s strategic partnership with MOHS will enable synergies as the strengths of both companies complement each other,” says Remedios A. Rivera, Remed chairman and president. “Remed can tap MOHS’s distribution expertise in channels it is not currently accessing, while MOHS can tap Remed’s field marketing force to push its health and wellness products to medical professionals. Such a strong partnership will unlock significant growth for Remed both locally and globally.